LaNCE-Neuropharm: Laboratorio de Neurociencia Clínica y Experimental para el estudio farmacológico de la neuroprotección-neurodegeneración-neurorregeneración
Hospital Universitario de la Princesa
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (6)
2023
-
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life
Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402
2021
-
Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1
Neurologia, Vol. 36, Núm. 2, pp. 149-158
-
Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2
Neurologia, Vol. 36, Núm. 2, pp. 159-168
2016
-
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression
BMC Neurology, Vol. 16, Núm. 1
-
One-year clinical experience of perampanel in Spain: A multicentre study of efficacy and tolerability
Epileptic Disorders, Vol. 18, Núm. 2, pp. 173-180
2012
-
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study
Movement Disorders, Vol. 27, Núm. 2, pp. 211-218